Agenus
AGEN
#8237
Rank
NZ$0.61 B
Marketcap
NZ$13.71
Share price
8.73%
Change (1 day)
76.60%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): NZ$0.20 Billion

According to Agenus 's latest financial reports the company's current earnings are NZ$0.12 Billion. In 2025 the company made an earning of NZ$91.17 Million, an increase over its 2024 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.20 B128.65%
2025 NZ$91.17 M-145.52%
2024 -NZ$0.21 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.3 Billion-556.26%
2021 NZ$64.63 M-130.37%
2020 -NZ$0.22 Billion73.75%
2019 -NZ$0.13 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.2 Billion26.55%
2015 -NZ$0.16 Billion110.24%
2014 -NZ$72.02 Million49.12%
2013 -NZ$48.3 Million
2011 -NZ$33.35 Million-12.25%
2010 -NZ$38.01 Million-21.41%
2009 -NZ$48.36 Million-26.86%
2008 -NZ$66.12 Million13.72%
2007 -NZ$58.14 Million-33.4%
2006 -NZ$87.3 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$0.11 Billion37.83%
2001 -NZ$72.73 Million55.99%
2000 -NZ$46.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.38 B 21,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.97 B 10,892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.76 B 7,921.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.48 B 8,267.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.54 Billion-358.33%๐Ÿ‡บ๐Ÿ‡ธ USA